According to this study, over the next five years the Drugs for Osteoarthritis Pain market will register a 5.9% CAGR in terms of revenue, the global market size will reach $ 10290 million by 2025, from $ 8174.6 million in 2019. In particular, this report presents the global revenue market share of key companies in Drugs for Osteoarthritis Pain business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Drugs for Osteoarthritis Pain market by type, application, key companies and key regions.

This study considers the Drugs for Osteoarthritis Pain value generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

Oral

Injection

External

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

Medical Care

Personal Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Pfizer

Mylan

Johnson & Johnson

Bayer

Eli Lilly

GlaxoSmithKline

Horizon Pharma

Novartis

Abbott

Sanofi

Iroko Pharmaceuticals

Abiogen Pharma

Hengrui Pharmaceutical

Daiichi Sankyo

Astellas Pharma

Almatica Pharma

Tide Pharmaceutical

TEVA

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Drugs for Osteoarthritis Pain market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Drugs for Osteoarthritis Pain market by identifying its various subsegments.

Focuses on the key global Drugs for Osteoarthritis Pain players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Drugs for Osteoarthritis Pain with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Drugs for Osteoarthritis Pain submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drugs for Osteoarthritis Pain Market Size 2015-2025

2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region

2.2 Drugs for Osteoarthritis Pain Segment by Type

2.2.1 Oral

2.2.2 Oral

2.2.3 External

2.3 Drugs for Osteoarthritis Pain Market Size by Type

2.3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2015-2020)

2.3.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (2015-2020)

2.4 Drugs for Osteoarthritis Pain Segment by Application

2.4.1 Medical Care

2.4.2 Personal Care

2.5 Drugs for Osteoarthritis Pain Market Size by Application

2.5.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2015-2020)

2.5.2 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (2015-2020)

3 Global Drugs for Osteoarthritis Pain by Players

3.1 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players

3.1.1 Global Drugs for Osteoarthritis Pain Market Size by Players (2018-2020)

3.1.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Players (2018-2020)

3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Drugs for Osteoarthritis Pain by Regions

4.1 Drugs for Osteoarthritis Pain Market Size by Regions

4.2 Americas Drugs for Osteoarthritis Pain Market Size Growth

4.3 APAC Drugs for Osteoarthritis Pain Market Size Growth

4.4 Europe Drugs for Osteoarthritis Pain Market Size Growth

4.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth

5 Americas

5.1 Americas Drugs for Osteoarthritis Pain Market Size by Countries

5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type

5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Drugs for Osteoarthritis Pain Market Size by Regions

6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type

6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Drugs for Osteoarthritis Pain by Countries

7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type

7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Countries

8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type

8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Drugs for Osteoarthritis Pain Market Forecast

10.1 Global Drugs for Osteoarthritis Pain Market Size Forecast (2021-2025)

10.2 Global Drugs for Osteoarthritis Pain Forecast by Regions

10.2.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2021-2025)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Drugs for Osteoarthritis Pain Forecast by Type

10.8 Global Drugs for Osteoarthritis Pain Forecast by Application

11 Key Players Analysis

11.1 Pfizer

11.1.1 Company Details

11.1.2 Drugs for Osteoarthritis Pain Product Offered

11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.1.4 Main Business Overview

11.1.5 Pfizer News

11.2 Mylan

11.2.1 Company Details

11.2.2 Drugs for Osteoarthritis Pain Product Offered

11.2.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.2.4 Main Business Overview

11.2.5 Mylan News

11.3 Johnson & Johnson

11.3.1 Company Details

11.3.2 Drugs for Osteoarthritis Pain Product Offered

11.3.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.3.4 Main Business Overview

11.3.5 Johnson & Johnson News

11.4 Bayer

11.4.1 Company Details

11.4.2 Drugs for Osteoarthritis Pain Product Offered

11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.4.4 Main Business Overview

11.4.5 Bayer News

11.5 Eli Lilly

11.5.1 Company Details

11.5.2 Drugs for Osteoarthritis Pain Product Offered

11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.5.4 Main Business Overview

11.5.5 Eli Lilly News

11.6 GlaxoSmithKline

11.6.1 Company Details

11.6.2 Drugs for Osteoarthritis Pain Product Offered

11.6.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.6.4 Main Business Overview

11.6.5 GlaxoSmithKline News

11.7 Horizon Pharma

11.7.1 Company Details

11.7.2 Drugs for Osteoarthritis Pain Product Offered

11.7.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.7.4 Main Business Overview

11.7.5 Horizon Pharma News

11.8 Novartis

11.8.1 Company Details

11.8.2 Drugs for Osteoarthritis Pain Product Offered

11.8.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.8.4 Main Business Overview

11.8.5 Novartis News

11.9 Abbott

11.9.1 Company Details

11.9.2 Drugs for Osteoarthritis Pain Product Offered

11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.9.4 Main Business Overview

11.9.5 Abbott News

11.10 Sanofi

11.10.1 Company Details

11.10.2 Drugs for Osteoarthritis Pain Product Offered

11.10.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2018-2020)

11.10.4 Main Business Overview

11.10.5 Sanofi News

11.11 Iroko Pharmaceuticals

11.12 Abiogen Pharma

11.13 Hengrui Pharmaceutical

11.14 Daiichi Sankyo

11.15 Astellas Pharma

11.16 Almatica Pharma

11.17 Tide Pharmaceutical

11.18 TEVA

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Drugs for Osteoarthritis Pain Market Size CAGR by Region 2015-2025 ($ Millions)

Table 4. Major